Prognostic Value of Tpeak-Tend Interval in Early Diagnosis of Duchenne Muscular Dystrophy Cardiomyopathy

Serra Baskan1, Pelin Karaca Ozer2, Huseyin Orta2

  • 1Department of Pediatric Cardiology, Istanbul Faculty of Medicine, Istanbul University, Istanbul 34134, Turkey.

Insights

The Tpeak-Tend interval, a measurement from ECGs, can help detect cardiac issues and early arrhythmia risk in Duchenne muscular dystrophy (DMD) patients. Prolonged Tpeak-Tend intervals predict a higher burden of premature ventricular contractions, indicating significant cardiac involvement.

Area of Science:

  • Cardiology
  • Pediatric Cardiology
  • Genetics

Background:

  • Cardiomyopathy is the leading cause of mortality in Duchenne muscular dystrophy (DMD).
  • Early identification of cardiac involvement and arrhythmic risk is crucial for managing DMD patients.
  • The Tpeak-Tend (Tp-e) interval is a novel electrocardiographic marker that may reflect ventricular repolarization abnormalities.

Purpose of the Study:

  • To investigate the association between the Tp-e interval and the burden of premature ventricular contractions (PVCs) in DMD patients.
  • To assess the utility of the Tp-e interval in predicting early arrhythmic risk and cardiac involvement in DMD.
  • To compare Tp-e intervals and other cardiac markers between DMD patient groups with varying PVC frequencies and healthy controls.

Main Methods:

  • A study involving 25 DMD patients, categorized into two groups based on 24-hour Holter monitoring for PVC frequency (<1% vs. >1%).
  • Comparison of electrocardiographic (ECG) parameters, including the Tp-e interval, and biochemical markers (Pro-BNP, troponin) with a control group of 27 healthy individuals.
  • Statistical analysis, including logistic regression, to identify independent predictors of high PVC burden and to evaluate the diagnostic performance of the Tp-e interval.

Main Results:

  • Patients with >1% PVCs (Group 2) exhibited lower left ventricular ejection fraction (LVEF) and larger LV end-diastolic diameter compared to Group 1 and controls.
  • Elevated Pro-BNP and troponin levels were observed in both DMD groups compared to controls.
  • A significantly longer Tp-e interval was found in Group 2 compared to Group 1 and controls.
  • Both LVEF and Tp-e interval were identified as independent predictors of PVC frequency >1% in DMD patients.
  • A Tp-e interval exceeding 71.65 ms demonstrated high sensitivity (80%) and specificity (90%) for predicting >1% PVCs.

Conclusions:

  • Prolongation of the Tp-e interval is associated with a higher burden of PVCs and may serve as an indicator of cardiac involvement in DMD.
  • The Tp-e interval, easily measurable from ECGs, can aid in the early diagnosis of arrhythmic risk in Duchenne muscular dystrophy patients.
  • Utilizing Tp-e interval measurements could enhance the monitoring and management strategies for cardiac complications in DMD.

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
11
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
201
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
16
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
23
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
12
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
38